Bnp Paribas Asset Management Holding S.A. Repligen Corp Transaction History

Bnp Paribas Asset Management Holding S.A.

$37.3 Billion
Q1 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Repligen Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 315,102 shares of RGEN stock, worth $41.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

315,102

Previous 328,455 4.07%

Holding current value

$41.5 Million

Previous $47.3 Million 15.2%

% of portfolio

0.11%

Previous 0.12%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$127.24 - $174.24 $1.7 Million - $2.33 Million	-13,353 Reduced 4.07%	315,102 $40.1 Million
Q4 2024 Feb 11, 2025	BUY	$123.41 - $160.92 $5.84 Million - $7.62 Million	47,329 Added 16.84%	328,455 $47.3 Million
Q3 2024 Nov 08, 2024	BUY	$119.79 - $167.35 $2.83 Million - $3.95 Million	23,625 Added 9.17%	281,126 $41.8 Million
Q2 2024 Jul 29, 2024	SELL	$120.0 - $182.95 $4.23 Million - $6.45 Million	-35,239 Reduced 12.04%	257,501 $32.5 Million
Q1 2024 May 08, 2024	SELL	$170.78 - $208.42 $6.51 Million - $7.94 Million	-38,108 Reduced 11.52%	292,740 $53.8 Million
Q4 2023 Feb 09, 2024	SELL	$114.17 - $185.35 $1.66 Million - $2.69 Million	-14,538 Reduced 4.21%	330,848 $59.5 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $1.36 Million - $1.73 Million	9,787 Added 2.92%	345,386 $54.9 Million
Q2 2023 Aug 08, 2023	BUY	$138.42 - $180.31 $15.8 Million - $20.5 Million	113,854 Added 51.34%	335,599 $47.5 Million
Q1 2023 May 08, 2023	BUY	$154.26 - $198.1 $7.95 Million - $10.2 Million	51,540 Added 30.28%	221,745 $37.3 Million
Q4 2022 Feb 09, 2023	BUY	$162.42 - $220.56 $1.79 Million - $2.43 Million	11,028 Added 6.93%	170,205 $28.8 Million
Q3 2022 Nov 10, 2022	SELL	$160.42 - $256.21 $1.26 Million - $2.01 Million	-7,836 Reduced 4.69%	159,177 $29.8 Million
Q2 2022 Aug 04, 2022	BUY	$140.68 - $188.02 $1.38 Million - $1.84 Million	9,802 Added 6.23%	167,013 $27.1 Million
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $2.29 Million - $3.67 Million	-14,225 Reduced 8.3%	157,211 $29.6 Million
Q4 2021 Feb 09, 2022	BUY	$247.59 - $304.47 $7.13 Million - $8.77 Million	28,801 Added 20.19%	171,436 $45.4 Million
Q3 2021 Nov 08, 2021	SELL	$194.77 - $324.21 $1.08 Million - $1.79 Million	-5,525 Reduced 3.73%	142,635 $41.2 Million
Q2 2021 Aug 05, 2021	BUY	$165.87 - $220.95 $5.43 Million - $7.23 Million	32,713 Added 28.34%	148,160 $29.6 Million
Q1 2021 May 05, 2021	BUY	$180.37 - $226.26 $20.8 Million - $26.1 Million	115,447 New	115,447 $22.4 Million
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $8.75 Million - $10.9 Million	-114,191 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$54.2 - $85.95 $1.44 Million - $2.29 Million	-26,642 Reduced 18.92%	114,191 $9.82 Million
Q1 2019 Apr 26, 2019	BUY	$49.45 - $62.8 $421,759 - $535,621	8,529 Added 6.45%	140,833 $8.32 Million
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $932,383 - $1.33 Million	-19,320 Reduced 12.74%	132,304 $6.79 Million
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $9.54 Million - $12 Million	-203,773 Reduced 57.34%	151,624 $8.41 Million
Q2 2018 Aug 01, 2018	BUY	$35.26 - $47.04 $795,677 - $1.06 Million	22,566 Added 6.78%	355,397 $16.7 Million
Q1 2018 May 07, 2018	BUY	$30.92 - $37.27 $17,655 - $21,281	571 Added 0.17%	332,831 $12 Million
Q4 2017 Feb 01, 2018	BUY	$32.53 - $38.92 $243,779 - $291,666	7,494 Added 2.31%	332,260 $12.1 Million
Q3 2017 Nov 02, 2017	BUY	$36.98 - $46.06 $12 Million - $15 Million	324,766	324,766 $12.4 Million

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.31B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Repligen Corp Transaction History